Mass Spectrometry Industry Insights and Strategic Analysis, 2030: Profiles the 12 Leading Players in the Forecasted $5.8 Billion Market
October 04, 2024 06:03 ET
|
Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "Mass Spectrometry - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Mass...
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
October 03, 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2024 16:00 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on September 30, 2024 it granted stock options to purchase an aggregate...
ProductLife Group (PLG) Acquires Nextep to Further Expand its Global Patient Access Capabilities
October 03, 2024 03:00 ET
|
Groupe Product Life
ProductLife Group (PLG is pleased to announce the acquisition of Nextep, a reputed French consultancy specialized in market access and public affairs.
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure
October 02, 2024 20:20 ET
|
Reneo Pharmaceuticals, Inc.
– Combined company to trade on Nasdaq under ticker “OKUR” – Reneo announces 1-for-10 reverse split of common stock IRVINE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc....
Cytokinetics to Host Investor & Analyst Day on October 16, 2024
October 02, 2024 16:00 ET
|
Cytokinetics, Incorporated
Company Leadership to Discuss Cardiac Myosin Modulation, Specialty Cardiology Programs and Commercial Launch Preparations SOUTH SAN FRANCISCO, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) --...
Keiretsu Forum Announces Dr. Martin Gershon as Keynote Speaker for 2024 Investor Capital Expo
October 02, 2024 07:08 ET
|
Keiretsu Forum Mid-Atlantic
This signature event in early-stage investment community will be held on October 31, 2024, at Convene City View in Philadelphia.
BioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot Ulcers
October 02, 2024 07:00 ET
|
BioStem Technologies, Inc.
BioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot Ulcers
Ocugen to Present at the 2024 Cell & Gene Meeting on the Mesa
October 02, 2024 06:30 ET
|
Ocugen
MALVERN, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
BioNTX Announces the 2024 Dennis K. Stone Award Recipient
October 01, 2024 10:48 ET
|
BioNTX
DALLAS, Oct. 01, 2024 (GLOBE NEWSWIRE) -- BioNTX, the bioscience and healthcare innovation trade organization serving North Texas, is pleased to introduce D. Jeff Keyser, RPh, JD, PhD as the...